Citius Oncology, Inc. (CTOR) earnings · $105.2M cap
These earnings events as JSON? API free 100/dayCitius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
This CTOR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CTOR revenue for 2026-06-30 was $1.5M. Net income was -$8.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.
When the next CTOR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 10.4% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full CTOR research stays on the stock page; the tape stays on the quote page.
CTOR earnings FAQ
What are CTOR's latest revenue and net income?
Latest cached Citius Oncology, Inc. (CTOR) revenue for Jun 30, 2026 was $1.5M. Net income was -$8.9M. Statements: https://lician.com/financials/ctor
What is CTOR's latest diluted EPS?
Latest cached Citius Oncology, Inc. (CTOR) diluted EPS for Jun 30, 2026 was -$0.08.
What period does the latest CTOR earnings print cover?
The latest cached Citius Oncology, Inc. (CTOR) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did CTOR revenue change from the prior cached period?
Cached Citius Oncology, Inc. (CTOR) revenue was down 10.4% from $1.7M (Mar 31, 2026) to $1.5M (Jun 30, 2026). Statements: https://lician.com/financials/ctor
Where are CTOR earnings listed?
Cached earnings facts for Citius Oncology, Inc. (CTOR) are listed at https://lician.com/earnings/ctor. Statements: https://lician.com/financials/ctor
Not investment advice.